发明名称 |
Method for identifying lineage-related antibodies |
摘要 |
In certain embodiments, the method may comprise: a) obtaining the antibody sequences from a population of B cells; b) grouping the antibody sequences to provide a plurality of groups of lineage-related antibodies; c) testing a single antibody from each of the groups in a bioassay and, after the first antibody has been identified, d) testing further antibodies that are in the same group as the first antibody in a second bioassay. In another embodiment, the method may comprise: a) testing a plurality of antibodies obtained from a first portion of an antibody producing organ of an animal; b) obtaining the sequence of a first identified antibody; c) obtaining from a second portion of said antibody producing organ the sequences of further antibodies that are related by lineage to said first antibody; and, c) testing the further antibodies in a second bioassay. |
申请公布号 |
US8969013(B2) |
申请公布日期 |
2015.03.03 |
申请号 |
US201313748507 |
申请日期 |
2013.01.23 |
申请人 |
EPITOMICS, Inc. |
发明人 |
Yu Guo-Liang |
分类号 |
C07K16/00;G01N33/53;G01N33/577;C07K16/28;G01N33/68;G01N33/566 |
主分类号 |
C07K16/00 |
代理机构 |
Bozicevic, Field & Francis, LLP |
代理人 |
Keddie James S.;Bozicevic, Field & Francis, LLP |
主权项 |
1. A method comprising:
a) obtaining antibody heavy chain sequences and antibody light chain sequences from a population of B cells of an animal, wherein said population of B cells comprises B cells that produce antibodies that specifically bind to a target antigen; b) grouping the antibodies based on their lineage to provide a plurality of groups of antibodies, wherein the antibodies in each group have heavy chain CDR3 regions that have 0, 1 or 2 amino acid substitutions relative to one another and light chain CDR3 regions that have 0, 1 or 2 amino acid substitutions relative to one another; c) testing a single antibody from each group of a plurality of the groups of b) in a first assay to identify a first antibody that has an activity; and, after said first antibody has been identified: d) testing a further antibody that is in the same group as the first antibody in a second assay, thereby identifying a second antibody that has said activity. |
地址 |
Burlingame CA US |